The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) ...

The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Celecoxib Capsules, marking another addition to its growing U.S.

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration ...

NEW DELHI: The Nifty Pharma index traded positive around 11:11AM (IST)on Tuesday in an upbeat market. Biocon Ltd. (up 1.75 ...

Benchmark NSE Nifty50 index ended down 67.55 points at 25082.3, while the BSE Sensex stood down 247.01 points at 82253.46.

Mutual Funds invested heavily in stocks, totaling Rs 45,900 crore. Consequently, cash reserves decreased from Rs 1.96 lakh ...

Zydus Lifesciences Ltd. detailed financials by Barron's. View 532321 business summary and company performance, for a clear financial breakdown.

JSW Steel Ltd., Tata Steel Ltd., Union Bank of India and Varroc Engineering Ltd. are some of the stocks to watch on Wednesday ...

Trump's threat of 200% tariff on pharmaceutical products could have severe implications on Indian drugmakers, as exports to the US form a significant share of their overall sales.

Macquarie reiterated its "outperform" rating on Sun Pharma with a price target of ₹2,135 apiece, due to its minimal exposure ...

Shares of Indian pharma companies fell on July 8 as investor concerns resurfaced following US President Trump’s announcement ...